Introducing mutations into a chromosomal rRNA gene using a genetically modified eubacterial host with a single rRNA operon

Molecular Microbiology
Peter SanderE C Böttger

Abstract

Gene-inactivation techniques were employed to construct a eubacterial organism harbouring a single functional rRNA operon. This mutant of Mycobacterium smegmatis permits replacement of the single remaining rRNA operon with a homologous fragment from a vector-borne gene. By homologous recombination with the chromosome a plasmid-borne rDNA segment with resistance markers substitutes for the corresponding region of the chromosomal rRNA operon, resulting in a homogeneous population of mutated ribosomes in the cell. As a first result we demonstrate that the single allelic knock-out strain allows for isolation of rRNA mutants with a drug-resistant phenotype, circumventing the problem of recessivity which prohibits the isolation of such mutants in organisms with multiple rRNA operons. Subsequently, by allelic exchange experiments, it was demonstrated that the rRNA mutation found indeed confers drug resistance in vivo. This system provides intriguing potential for the study of the structure and function of ribosomal RNAs.

Citations

Nov 12, 2005·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·A Lewin, S Sharbati-Tehrani
Jan 19, 2013·World Journal of Microbiology & Biotechnology·Hum Nath JnawaliYoung Kil Park
Jul 4, 2012·The Journal of Microbiology·Jorge A Gonzalez-Y-MerchandRobert A Cox
Apr 28, 2004·Molecular and Biochemical Parasitology·Alexander MathisErik C Boettger
Feb 19, 2003·Journal of Molecular Biology·Quentin Vicens, Eric Westhof
Sep 27, 2002·Current Opinion in Pharmacology·David J C KnowlesAlastair I H Murchie
Dec 1, 2009·Nature Chemical Biology·Michael B FeldmanScott C Blanchard
Dec 24, 2008·Proceedings of the National Academy of Sciences of the United States of America·Sven N HobbieErik C Böttger
Jul 8, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Frederick A SirgelAndré Trollip
Apr 18, 2001·EMBO Reports·E C BöttgerP Sander
Sep 4, 2007·Nucleic Acids Research·Sven N HobbieErik C Böttger
Aug 23, 2006·Antimicrobial Agents and Chemotherapy·Rita BerisioErik C Böttger
Sep 6, 2012·Antimicrobial Agents and Chemotherapy·Sumantha SalianErik C Böttger
Jul 7, 2011·Antimicrobial Agents and Chemotherapy·Subramanian AkshayRashid Akbergenov
Sep 15, 2001·Antimicrobial Agents and Chemotherapy·B SpringerP Sander
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·Peter SanderErik C Böttger
Apr 24, 2003·Antimicrobial Agents and Chemotherapy·P PfisterE C Böttger
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Sven N HobbieErik C Böttger
Jul 15, 2003·Clinical Microbiology Reviews·Issar Smith
Nov 18, 2008·Journal of Bacteriology·Carolin GüthleinBurkhard Springer
Mar 30, 2005·Proceedings of the National Academy of Sciences of the United States of America·Peter PfisterErik C Böttger
Sep 18, 2013·Antimicrobial Agents and Chemotherapy·Cédric OrelleAlexander S Mankin
Jan 22, 2015·The Journal of Antimicrobial Chemotherapy·Florian P MaurerErik C Böttger
Feb 24, 2006·Trends in Biotechnology·Erik C Böttger
Jun 3, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E C Böttger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Bacterial Respiration

This feed focuses on cellular respiration in bacteria, known as bacterial respiration. Discover the latest research here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.